Search research articles
Contact Us
Filters
Showing results (41-50 of 65) with videos related to
Page
of 7
Sort By:
The Journal of Biological Chemistry
|
June 4, 2002
Influences of base excision repair defects on the lethality and mutagenicity induced by Me-lex, a sequence-selective N3-adenine methylating agent
Paola Monti, Paola Campomenosi, Yari Ciribilli, et al.
Frontiers in Oncology
|
November 16, 2020
Heterogeneity of <i>TP53</i> Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
Paola Monti, Paola Menichini, Andrea Speciale, et al.
Scientific Reports
|
September 15, 2018
Etoposide-resistance in a neuroblastoma model cell line is associated with 13q14.3 mono-allelic deletion and miRNA-15a/16-1 down-regulation
Barbara Marengo, Paola Monti, Mariangela Miele, et al.
Human Mutation
|
March 7, 2013
EEC- and ADULT-associated TP63 mutations exhibit functional heterogeneity toward P63 responsive sequences
Paola Monti, Debora Russo, Renata Bocciardi, et al.
Cells
|
January 12, 2021
Antitumor Effects of PRIMA-1 and PRIMA-1<sup>Met</sup> (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?
Paola Menichini, Paola Monti, Andrea Speciale, et al.
Nucleic Acids Research
|
July 30, 2013
Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code
Yari Ciribilli, Paola Monti, Alessandra Bisio, et al.
Journal of Personalized Medicine
|
February 10, 2021
Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma
Barbara Marengo, Alessandra Pulliero, Maria Valeria Corrias, et al.
Frontiers in Immunology
|
September 8, 2023
The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers
Chiara M Biatta, Michele Paudice, Marco Greppi, et al.
European Journal of Haematology
|
March 4, 2021
Validation of the Alternative International Prognostic Score-E (AIPS-E): Analysis of Binet stage A chronic lymphocytic leukemia patients enrolled into the O-CLL1-GISL protocol
Fortunato Morabito, Giovanni Tripepi, Ernesto Vigna, et al.
Non-Coding RNA
|
March 19, 2020
NEAT1 Long Isoform Is Highly Expressed in Chronic Lymphocytic Leukemia Irrespectively of Cytogenetic Groups or Clinical Outcome
Domenica Ronchetti, Vanessa Favasuli, Paola Monti, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 65) with videos related to
Sort By:
Page
of 7
The Journal of Biological Chemistry
|
June 4, 2002
Influences of base excision repair defects on the lethality and mutagenicity induced by Me-lex, a sequence-selective N3-adenine methylating agent
Paola Monti, Paola Campomenosi, Yari Ciribilli, et al.
Frontiers in Oncology
|
November 16, 2020
Heterogeneity of <i>TP53</i> Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
Paola Monti, Paola Menichini, Andrea Speciale, et al.
Scientific Reports
|
September 15, 2018
Etoposide-resistance in a neuroblastoma model cell line is associated with 13q14.3 mono-allelic deletion and miRNA-15a/16-1 down-regulation
Barbara Marengo, Paola Monti, Mariangela Miele, et al.
Human Mutation
|
March 7, 2013
EEC- and ADULT-associated TP63 mutations exhibit functional heterogeneity toward P63 responsive sequences
Paola Monti, Debora Russo, Renata Bocciardi, et al.
Cells
|
January 12, 2021
Antitumor Effects of PRIMA-1 and PRIMA-1<sup>Met</sup> (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?
Paola Menichini, Paola Monti, Andrea Speciale, et al.
Nucleic Acids Research
|
July 30, 2013
Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code
Yari Ciribilli, Paola Monti, Alessandra Bisio, et al.
Journal of Personalized Medicine
|
February 10, 2021
Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma
Barbara Marengo, Alessandra Pulliero, Maria Valeria Corrias, et al.
Frontiers in Immunology
|
September 8, 2023
The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers
Chiara M Biatta, Michele Paudice, Marco Greppi, et al.
European Journal of Haematology
|
March 4, 2021
Validation of the Alternative International Prognostic Score-E (AIPS-E): Analysis of Binet stage A chronic lymphocytic leukemia patients enrolled into the O-CLL1-GISL protocol
Fortunato Morabito, Giovanni Tripepi, Ernesto Vigna, et al.
Non-Coding RNA
|
March 19, 2020
NEAT1 Long Isoform Is Highly Expressed in Chronic Lymphocytic Leukemia Irrespectively of Cytogenetic Groups or Clinical Outcome
Domenica Ronchetti, Vanessa Favasuli, Paola Monti, et al.
Page
of 7